Users Discontinuing Slimming Medications Put On Pounds Four Times Faster Than People Using Diet and Exercise

A recent study reveals that individuals who come off blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who stop traditional lifestyle regimens.

Findings released in a prominent medical journal points out that while obese individuals can lose about a fifth of their body weight while on the medication, the mass returns at an average rate of 0.8 kg per month after stopping.

"People buying such drugs should be informed of the risk of fast rebound weight gain when the therapy is stopped," stated researcher Dr. Susan Jebb.

This pace of regain suggests a reversion to pre-treatment weight within about a year and a half.

Comparing Approaches

The analysis, which looked at dozens of trials involving thousands of patients, contrasted the effects of GLP-1 agonists with older methods.

Scientists point out that individuals who lose weight through lifestyle changes alone usually see a slower creep back—approximately 0.1 kg a month—after stopping.

Explaining the Quick Rebound

Doctors propose the mechanism of the jabs accounts for the accelerated rebound.

These medications imitate a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the system to produce less of its own natural hormone, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating a significant risk."

A Chronic Disease?

Medical guidelines recommend the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians contend that, given the high risk of relapse, the therapy might need to be ongoing.

This opinion is reinforced by drug manufacturers, who say that the results "highlight the long-term character of excess weight," akin to managing diseases like high blood pressure.

Patient Testimonies

People who have stopped the medication explain a sudden resurgence of hunger.

"It was like a switch flipping and I was suddenly starving," recalled an individual.

The struggle is exacerbated if users have not adopted sustainable dietary or behavioural changes during therapy.

Significant Adoption

Survey data show that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.

• Adoption is more common among females than men.
• The middle-aged demographic shows the greatest level of interest.
• Many obtain the medications through private healthcare rather than the NHS.

In conclusion, clinicians caution that while the jabs are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits hinges on combined behavioural management.